Why the study?
Does a new self-expanding aortic bioprosthesis and 16-F delivery system demonstrate feasibility and stable hemodynamics in a sheep model?
Does a new self-expanding aortic bioprosthesis and 16-F delivery system demonstrate feasibility and stable hemodynamics in a sheep model?
A newly developed self-expanding aortic bioprosthesis and 16-F delivery system demonstrated preliminary feasibility and stable hemodynamics in a sheep model.
Supports preclinical feasibility in sheep; hypothesis-generating and leaves open human translation pending trials.
We sought to evaluate the feasibility and hemodynamic performance of a new self-expanding bioprosthesis and 16-F delivery system in sheep. A 23-mm new self-expanding aortic bioprosthesis was implanted in sheep (n = 10) with a 16-F catheter via the right common carotid artery. Each sheep underwent angiography and coronary angiography before intervention, immediately and 1 h after stent implantation. Electrocardiographic monitoring was carried out during and 2 h after the procedure. Transthoracic echocardiography was employed to detect hemodynamic performance before intervention, immediately and 1 and 2 h after stent implantation. All sheep were euthanized 2 h after successful implantation for macroscopic inspection. In all cases, the new self-expanding aortic bioprosthesis was successfully delivered to the aortic root and released with a 16-F catheter. Successful implantation was achieved in 8 of 10 sheep. Hemodynamic performance and device position of successful implantation were stable 2 h after device deployment. Atrioventricular block was not observed. We conclude that it is feasible to implant the new self-expanding aortic valve with a 16-F delivery system into sheep hearts via the retrograde route.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: